THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTCommon Stock Purchase Warrant • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • Delaware
Arno Therapeutics, Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that NAME, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after June 2, 2008 and on or before 5:00 p.m. (Eastern time) on June 2, 2013 (the “Exercise Period”), [*] shares of common stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of Two Dollars and Forty Two Cents ($2.42) per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively. This Warrant is one of a series of Warrants issued by the Company, all with the same Original Issue Date and of like tenor, except as to the number of Warrant Shares subject t
EMPLOYMENT AGREEMENTEmployment Agreement • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • New York
This EMPLOYMENT AGREEMENT (the “Agreement”) is made this 1st day of June 2007, by and between ARNO THERAPEUTICS, INC., a Delaware corporation with principal executive offices at 689 5th Avenue, 14th Floor, New York, NY 10022, (the “Company”), and SCOTT FIELDS, M.D., residing at 28 Doremus Drive, Towaco, New Jersey, 07082 (the “Executive”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • Delaware
This Subscription Agreement (this “Agreement”) is made as of the date set forth on the signature page of this Agreement by and between Arno Therapeutics, Inc., a Delaware corporation (the “Company”), and each party who is a signatory hereto (individually, a “Subscriber” and collectively with other signatories of similar subscription agreements entered into in connection with the Offering described below, the “Subscribers”).
CONFIDENTIAL TREATMENT REQUESTED Information marked by [***] has been omitted pursuant to a request for confidential treatment. The omitted portion has been separately filed with the Securities and Exchange Commission. LICENSE AGREEMENTLicense Agreement • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • Ohio
This Agreement is entered into on January 3, 2008, between THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION, located at 1960 Kenny Road, Columbus, Ohio and ARNO THERAPEUTICS, INC., a Delaware corporation located at 30 Two Bridges Rd., Suite 270, Fairfield, NJ 07004.
CONFIDENTIAL TREATMENT REQUESTED Information marked by [***] has been omitted pursuant to a request for confidential treatment. The omitted portion has been separately filed with the Securities and Exchange Commission. EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • Kentucky
This Agreement is made and entered into as of the 25th day of October, 2006 (“Effective Date”), by and between the University of Pittsburgh – Of the Commonwealth System of Higher Education, a non-profit corporation organized and existing under the laws of the Commonwealth of Pennsylvania, with an office at 200 Gardner Steel Conference Center, Thackeray and O’Hara Streets, Pittsburgh, Pennsylvania 15260 (“University”), and Arno Therapeutics, Inc., with its principal business at 689 Fifth Avenue, 14th Floor, New York, NY 10022 (“Licensee”).
Arno Therapeutics, Inc. [FORM OF][Incentive Stock] option AgreementIncentive Stock Option Agreement • June 9th, 2008 • Arno Therapeutics, Inc • Books: publishing or publishing & printing • Delaware
This Incentive Stock Option Agreement is made and entered into as of the __ day of _____________________, 200__ , between _____________________ (“Employee”) and Arno Therapeutics, Inc., a Delaware corporation (the “Company”).
